Liver-specific DPP4 transgenic mice presented not only elevated systemic DPP4 activity but also a NAFLD-associated syndrome including obesity, hypercholesterolemia, hepatic steatosis, and liver damage (11). Here, DPP4 is linked to Hepatic steatosis.